Idiopathic Pulmonary Fibrosis

Advances in Diagnostic Tools and Disease Management

Nonfiction, Health & Well Being, Medical, Specialties, Pulmonary & Thoracic, Science & Nature, Science, Biological Sciences, Biochemistry
Cover of the book Idiopathic Pulmonary Fibrosis by , Springer Japan
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9784431555827
Publisher: Springer Japan Publication: September 28, 2015
Imprint: Springer Language: English
Author:
ISBN: 9784431555827
Publisher: Springer Japan
Publication: September 28, 2015
Imprint: Springer
Language: English

From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.

More books from Springer Japan

Cover of the book Gene Therapy and Cell Therapy Through the Liver by
Cover of the book Marine Protists by
Cover of the book Robotic Surgery by
Cover of the book Functional Evaluation of Stroke Patients by
Cover of the book Nitric Oxide in the Eye by
Cover of the book Neuroprotection and Regeneration of the Spinal Cord by
Cover of the book Coronary Angioscopy by
Cover of the book Disaster Management and Private Sectors by
Cover of the book Ecology of Leaf Longevity by
Cover of the book Normally-Off Computing by
Cover of the book Gröbner Bases by
Cover of the book Semaphorins by
Cover of the book Real and Complex Submanifolds by
Cover of the book Clinical Guidelines in Urological Management by
Cover of the book Human-Harmonized Information Technology, Volume 1 by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy